A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species

Toxicology and Applied Pharmacology

Volumn 198, Issue 3, 2004, Pages 327-335

  Vasken Aposhian, H ^a   Zakharyan, Robert A ^a   Avram, Mihaela D ^a   Sampayo Reyes, Adriana ^a   Wollenberg, Michael L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Arsenic; Detoxication; DMA; generic term including DMA III and DMA V; generic term including MMA III and MMA V; Hydrogen peroxide; MMA; MMA III; MMA V; monomethylarsonic acid; monomethylarsonous acid

Indexed keywords

ARSENIC; ARSENIC DERIVATIVE; ARSENIC METHYLTRANSFERASE; ARSENIC TRIOXIDE; CACODYLIC ACID; DIMETHYLARSENOUS ACID; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; METHANEARSONIC ACID; METHYLTRANSFERASE; MONOMETHYLARSONOUS ACID; UNCLASSIFIED DRUG;

ARSENIC POISONING; BIOTRANSFORMATION; CONTROLLED STUDY; DETOXIFICATION; ENZYMOLOGY; HUMAN; HUMAN CELL; METABOLISM; METHYLATION; OXIDATION; REVIEW;

ANIMALS; ARSENIC; ARSENICALS; BIOTRANSFORMATION; CACODYLIC ACID; HUMANS; HYDROGEN PEROXIDE; LIVER; METABOLIC DETOXICATION, DRUG; METHYLATION;

EID: 3242801408     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.10.027     Document Type: Review

References (63)

1. Ahmad K., Kitchin K.T., Cullen W.R. Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch. Biochem. Biophys. 382:2000;195-202
2. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37:1997;397-419
3. III), excreted in human urine. Toxicol. Appl. Pharmacol. 165:2000;74-83
4. Aposhian H.V., Gurzau E.S., Le X.C., Gurzau A., Healy S.M., Lu X., Ma M., Yip L., Zakharyan R.A., Maiorino R.M., Dart R.C., Tircus M.G., Gonzalez-Ramirez D., Morgan D.L., Avram D., Aposhian M.M. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13:2000;693-697
5. Aposhian H.V., Zakharyan R.A., Avram M.D., Kopplin M.J., Wollenberg M.L. Oxidation and detoxification of trivalent arsenic species. Toxicol. Appl. Pharmacol. 193:2003;1-8
6. Barchowsky A., Klei L.R., Dudek E.J., Swartz H.M., James P.E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med. 27:1999;1405-1412
7. Board P.G., Coggan M., Chelvanayagam G., Simon E., Jermiin L.S., Schulte G.K., Danley D.E., Hoth L.R., Griffor M.C., Kamath A.V., Rosner M.H., Chrunyk B.A., Perregaux D.E., Gabel C.A., Geoghegan K.F., Pandit J. Identification, characterization, and crystal structure of the omega class glutathione transferases. J. Biol. Chem. 275:2000;24798-24806
8. Buchet J.P., Lauwerys R. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch. Toxicol. 57:1985;125-129
9. Chakraborti D., Mohammed M.R., Paul K., Chowdhury U.K., Sengupta M.K., Lodh D., Chanda C.R., Saha K.C., Mukherjee S.C. Arsenic calamity in the Indian subcontinent. What lessons have been learned? Talanta. 58:2002;3-22
10. Cullen W.R., Reimer K.J. Arsenic speciation in the environment. Chem. Rev. 89:1989;713-764
11. Cullen W.R., McBride B.C., Reglinski J. The reaction of methylarsenicals with thiols: some biological implications. J. Inorg. Biochem. 21:1984;179-194
12. Del Razo L.M., Styblo M., Cullen W.R., Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 174:2001;282-293
13. Dulhunty A., Gage P., Curtis S., Chelvanayagam G., Board P. The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J. Biol. Chem. 276:2001;3319-3323
14. Enroth C., Eger B.T., Okamoto K., Nishino T., Nishino T., Pai E.F. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc. Natl. Acad. Sci. U.S.A. 97:2000;10723-10728
15. Gong Z., Lu X., Cullen W.R., Le X.C. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J. Anal. At. Spectrom. 16:2001;1409-1413
16. Gregus Z., Németi B. Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci. 70:2002;13-19
17. Healy S.M., Zakharyan R.A., Aposhian H.V. Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig. Mutat. Res. 386:1997;229-239
18. Hille R. The mononuclear molybdenum enzymes. Chem. Rev. 96:1996;2757-2816
19. Hille R., Nishino T. Xanthine oxidase and xanthine dehydrogenase. FASEB J. 9:1995;995-1003
20. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133:2002;1-16
21. Hunter F.T., Kip A.F., Irvine J.W. Jr. Radioactive tracer studies on arsenic injected as potassium arsenite. J. Pharmacol. Exp. Ther. 76:1942;207-220
22. Kala S.V., Neely M.W., Kala G., Prater C.I., Atwood D.W., Rice J.S., Lieberman M.W. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275:2000;33404-33408
23. Klaasen C.D. Biliary excretion of arsenic in rats, rabbits and dogs. Toxicol. Appl. Pharmacol. 29:1974;447-457
24. 74 as a tracer. Univ. Calif. Publ., Pharmacol. 2:1950;263-282
25. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72:2000;5172-5177
26. Le X.C., Ma M., Lu X., Cullen W.R., Aposhian H.V., Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 108:2000;1015-1018
27. Lin S., Shi Q., Nix F.B., Styblo M., Beck M.A., Herbin-Davis K.M., Hall L.L., Simeonsson J.B., Thomas D.J. A novel S-Adenosyl-L-Methionine: arsenic (III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277:2002;10795-10803
28. Liu S.X., Athar M., Lippai I., Waldren C., Hei Tom K. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U.S.A. 98:2001;1643-1648
29. Liu Z., Shen J., Carbrey J.M., Mukhopadhyay R., Agre P., Rosen B.P. Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9. Proc. Natl. Acad. Sci. U.S.A. 99:2002;6053-6058
30. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 14:2001;371-378
31. V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. Chem. Res. Toxicol. 16:2003;1507-1513
32. Mihalik S.J., Rhead W.J. L-pipecolic acid oxidation in the rabbit and cynomolgus monkey. Evidence for differing organellar locations and cofactor requirements in each species. J. Biol. Chem. 264:1989;2509-2517
33. National Research Council Report Arsenic in Drinking Water. 1999;National Academy Press, Washington, DC
34. National Research Council Report, 2001. Arsenic in Drinking Water: 2001 Update. Subcommittee to update the 1999 arsenic in drinking water report, Committee on Toxicology, Board on Environmental Studies and Toxicology.
35. Németi B., Gregus Z. Reduction of arsenate to arsenite in hepatic cytosol. Toxicol. Sci. 70:2002;4-12
36. Németi B., Csanaky I., Gregus Z. Arsenate reduction in human erythrocytes and rats - Testing the role of purine nucleoside phosphorylase. Toxicol. Sci. 74:2003;22-31
37. Nesnow S., Roop B.C., Lambert G., Kadiiska M., Mason R.P., Cullen W.R., Mass M. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15:2002;1627-1634
38. Nordstrom D.K. Worldwide occurrences of arsenic in ground water. Science. 296:2002;2143-2145
39. Parks D.A., Granger D.N. Xanthine oxidase: biochemistry distribution and physiology. Acta Physiol. Scand. 548:1986;87-99
40. Patterson T.J., Ngo M., Aronov P.A., Reznikova T.V., Green P.G., Rice R.H. Biological activity of inorganic arsenic and antimony reflects oxidation state in cultured human keratinocytes. Chem. Res. Toxicol. 16:2003;1624-1631
41. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163:2000;203-207
42. 50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14:2001;651-656
43. Radabaugh T.R., Aposhian H.V. Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem. Res. Toxicol. 13:2000;26-30
44. Radabaugh T.R., Sampayo-Reyes A., Zakharyan R.A., Aposhian H.V. Arsenate reductase: II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15:2002;692-698
45. Rossman T.G., Uddin A.N., Burns F.J., Bosland M.C. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol. 176:2001;64-71
46. Salinas A.E., Wong M.G. Glutathione S-transferase. Curr. Med. Chem. 6:1999;279-309
47. Samikkannu T., Chen C.-H.C., Yih L.-H., Wang A.S.S., Lin S.-Y., Chen T.-C., Jan K.-Y. Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem. Res. Toxicol. 16:2002;409-414
48. Sampayo-Reyes A., Zakharyan R.A., Healy S.M., Aposhian H.V. Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem. Res. Toxicol. 13:2000;1181-1186
49. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:2000;289-299
50. Tamura H., Iida T., Watanabe T., Suga T. Long-term effects of peroxisome proliferators on the balance between hydrogen peroxide-generating and scavenging capacities in the liver of Fisher-344 rats. Toxicology. 63:1990;199-213
51. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor β1. J. Biol. Chem. 270:1995;30334-30338
52. Thomas D.J., Styblo M., Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176:2001;127-144
53. Vahter M. Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem. 8:1994;175-182
54. Vahter M., Marafante E. In vivo methylation and detoxication of arsenic. Craig P.J., Glocking F. The Biological Alkylation of Heavy Elements. Spec. Publ.-R. Soc. Chem., Lond. vol. 66:1988;105-119
55. Vahter M., Couch R., Nermell B., Nilsson R. Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol. Appl. Pharmacol. 133:1995;262-268
56. Wildfang E., Radabaugh T.R., Aposhian H.V. Enzymatic methylation of arsenic compounds: IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology. 168:2001;213-221
57. Yin Z.-L., Dahlstrom J.E., LeCouteur D.G., Board P.G. Immunohistochemistry of omega class glutathione S-transferase in human tissues. J. Histochem. Cytochem. 49:2001;983-988
58. Zakharyan R.A., Aposhian H.V. Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. Chem. Res. Toxicol. 12:1999;1278-1283
59. Zakharyan R.A., Wu Y., Bogdan G.M., Aposhian H.V. Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 8:1995;1029-1038
60. Zakharyan R.A., Wildfang E., Aposhian H.V. Enzymatic methylation of arsenic compounds: III. The marmoset and tamarin, but not the rhesus monkey, are deficient in methyltransferase that methylate inorganic arsenic. Toxicol. Appl. Pharmacol. 140:1996;77-84
61. Zakharyan R.A., Ayala-Fierro F., Cullen W.R, Carter D.M., Aposhian H.V. Enzymatic methylation of arsenic compounds: VII. Monomethylarsonous acid [MMA(III)] is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158:1999;9-15
62. Zakharyan R.A., Sampayo-Reyes A., Healy S.M., Tsaprailis G., Board P.G., Liebler D.C., Aposhian H.V. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. 14:2001;1051-1057
63. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10907-10912